Medicine, Hematology Oncology Division

Research Output

Filter
Article
2018

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Shah, A. N. & Gradishar, W. J., Aug 17 2018, In : The oncologist.

Research output: Contribution to journalArticle

4 Scopus citations

Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations

Kugel, C. H., Douglass, S. M., Webster, M. R., Kaur, A., Liu, Q., Yin, X., Weiss, S. A., Darvishian, F., Al-Rohil, R. N., Ndoye, A., Behera, R., Alicea, G. M., Ecker, B. L., Fane, M., Allegrezza, M. J., Svoronos, N., Kumar, V., Wang, D. Y., Somasundaram, R., Hu-Lieskovan, S. & 23 others, Ozgun, A., Herlyn, M., Conejo-Garcia, J. R., Gabrilovich, D., Stone, E. L., Nowicki, T. S., Sosman, J., Rai, R., Carlino, M. S., Long, G. V., Marais, R., Ribas, A., Eroglu, Z., Davies, M. A., Schilling, B., Schadendorf, D., Xu, W., Amaravadi, R. K., Menzies, A. M., McQuade, J. L., Johnson, D. B., Osman, I. & Weeraratna, A. T., Nov 1 2018, In : Clinical Cancer Research. 24, 21, p. 5347-5356 10 p.

Research output: Contribution to journalArticle

68 Scopus citations
15 Scopus citations

A multicenter phase I study evaluating dual PI3K and BRAF inhibition with PX-866 and vemurafenib in patients with advanced BRAF V600-mutant solid tumors

Yam, C., Xu, X., Davies, M. A., Gimotty, P. A., Morrissette, J. J. D., Tetzlaff, M. T., Wani, K. M., Liu, S., Deng, W., Buckley, M., Zhao, J., Amaravadi, R. K., Haas, N. B., Kudchadkar, R. R., Pavlick, A. C., Sosman, J. A., Tawbi, H., Walker, L., Schuchter, L. M., Karakousis, G. C. & 1 others, Gangadhar, T. C., Jan 1 2018, In : Clinical Cancer Research. 24, 1, p. 22-32 11 p.

Research output: Contribution to journalArticle

11 Scopus citations

Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib

Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations

Pulliam, N., Fang, F., Ozes, A. R., Tang, J., Adewuyi, A., Keer, H., Lyons, J., Baylin, S. B., Matei, D., Nakshatri, H., Rassool, F. V., Miller, K. D. & Nephew, K. P., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3163-3175 13 p.

Research output: Contribution to journalArticle

29 Scopus citations

A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

Levis, M. J., Perl, A. E., Altman, J. K., Gocke, C. D., Bahceci, E., Hill, J., Liu, C., Xie, Z., Carson, A. R., McClain, V., Stenzel, T. T. & Miller, J. E., Apr 24 2018, In : Blood Advances. 2, 8, p. 825-831 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Berlin, J. D., Feng, Y., Catalano, P., Abbruzzese, J. L., Philip, P. A., McWilliams, R. R., Lowy, A. M., Benson, A. B. & Blackstock, A. W., Jan 1 2018, In : Oncology (Switzerland). 94, 1, p. 39-46 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

ANP32A regulates histone H3 acetylation and promotes leukemogenesis

Yang, X., Lu, B., Sun, X., Han, C., Fu, C., Xu, K., Wang, M., Li, D., Chen, Z., Opal, P., Wen, Q., Crispino, J. D., Wang, Q. F. & Huang, Z., Jul 1 2018, In : Leukemia. 32, 7, p. 1587-1597 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Antibody-based therapies in patients with acute lymphoblastic leukemia

Dinner, S. & Liedtke, M., Nov 30 2018, In : Hematology (United States). 2018, 1, p. 9-15 7 p.

Research output: Contribution to journalArticle

Open Access
9 Scopus citations

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

Brisard, D., Eckerdt, F., Marsh, L. A., Blyth, G. T., Jain, S., Cristofanilli, M., Horiuchi, D. & Platanias, L. C., Dec 1 2018, In : Oncotarget. 9, 99, p. 37305-37318 14 p.

Research output: Contribution to journalArticle

2 Scopus citations

Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)

Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 others, King, A. D., Erlichman, C., Yin, J., Costello, B. A. & Chan, A. T. C., 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.

Research output: Contribution to journalArticle

81 Scopus citations

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Dinner, S., Dunn, T. J., Price, E., Coutré, S. E., Gotlib, J., Berube, C., Kaufman, G. P., Medeiros, B. C. & Liedtke, M., Sep 1 2018, In : International journal of hematology. 108, 3, p. 267-273 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In : Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

Gounder, M., Schöffski, P., Villalobos, V., Cote, G., Chugh, R., Chen, T. W. W., Jahan, T., Loggers, E. T., Italiano, A., Gupta, A., Agulnik, M., Attia, S., Jones, R. L., van Tine, B. A., Demetri, G. D. D., Roche, M., Sapir, I., Daigle, S., Clawson, A. & Stacchiotti, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii581-viii582

Research output: Contribution to journalArticle

Open Access

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)

Jones, R. L., Blay, J. Y., Agulnik, M., Chugh, R., Mir, O., Italiano, A., Thomas, D., Gupta, A., Jahan, T., Cote, G., Villalobos, V., Demetri, G. D. D., Roche, M., Sapir, I., Daigle, S., Clawson, A. & Gounder, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii580-viii581

Research output: Contribution to journalArticle

Open Access

A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region

Fizazi, K., Hussain, M., Saad, F., Shore, N., De Giorgi, U., Efstathiou, E., Ferreira, U., Ivashchenko, P., Madziarska, K., Al-Adhami, M., Modelska, K., Phung, D., Steinberg, J. & Sternberg, C. N., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii277-viii278

Research output: Contribution to journalArticle

Open Access

A Phase II Study of Celecoxib with Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Previously Untreated Advanced or Metastatic Colorectal Cancer

Chen, E. Y., Blanke, C. D., Haller, D. G., Benson III, A. B., Dragovich, T., Lenz, H. J., Robles, C., Li, H., Mori, M., Mattek, N., Sanborn, R. E. & Lopez, C. D., Dec 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 12, p. 1193-1198 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

van Tine, B. A., Mohindra, N., Milhem, M., Attia, S., Robinson, S. I., Rademaker, A., Okuno, S. H. & Agulnik, M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii579

Research output: Contribution to journalArticle

Open Access

A phase ii study of pelareorep (REOLYSIN®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

Mahalingam, D., Goel, S., Aparo, S., Arora, S. P., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G. & Mita, M. M., Jun 2018, In : Cancers. 10, 6, 160.

Research output: Contribution to journalArticle

25 Scopus citations

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

Santa-Maria, C. A., Kato, T., Park, J. H., Kiyotani, K., Rademaker, A., Shah, A. N., Gross, L., Blanco, L. Z., Jain, S., Flaum, L., Tellez, C., Stein, R., Uthe, R., Gradishar, W. J., Cristofanilli, M., Nakamura, Y. & Giles, F. J., Apr 10 2018, In : Oncotarget. 9, 27, p. 18985-18996 12 p.

Research output: Contribution to journalArticle

21 Scopus citations

A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)

Tanabe, P., Silva, S., Bosworth, H. B., Crawford, R., Paice, J. A., Richardson, L. D., Miller, C. N. & Glassberg, J., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 159-168 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function

Li, S., Bostick, J. W., Ye, J., Qiu, J., Zhang, B., Urban, J. F., Avram, D. & Zhou, L., Nov 20 2018, In : Immunity. 49, 5, p. 915-928.e5 1 p.

Research output: Contribution to journalArticle

28 Scopus citations
Open Access

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

McQuade, J. L., Daniel, C. R., Hess, K. R., Mak, C., Wang, D. Y., Rai, R. R., Park, J. J., Haydu, L. E., Spencer, C., Wongchenko, M., Lane, S., Lee, D. Y., Kaper, M., McKean, M., Beckermann, K. E., Rubinstein, S. M., Rooney, I., Musib, L., Budha, N., Hsu, J. & 26 others, Nowicki, T. S., Avila, A., Haas, T., Puligandla, M., Lee, S., Fang, S., Wargo, J. A., Gershenwald, J. E., Lee, J. E., Hwu, P., Chapman, P. B., Sosman, J. A., Schadendorf, D., Grob, J. J., Flaherty, K. T., Walker, D., Yan, Y., McKenna, E., Legos, J. J., Carlino, M. S., Ribas, A., Kirkwood, J. M., Long, G. V., Johnson, D. B., Menzies, A. M. & Davies, M. A., Mar 2018, In : The Lancet Oncology. 19, 3, p. 310-322 13 p.

Research output: Contribution to journalArticle

129 Scopus citations

Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer

Goodman, C. R., Seagle, B. L. L., Friedl, T. W. P., Rack, B., Lato, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S. & Strauss, J. B., Aug 2018, In : JAMA Oncology. 4, 8, e180163.

Research output: Contribution to journalArticle

37 Scopus citations

Association of survival with adherence to the American cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis the calgb 89803/alliance trial

Van Blarigan, E. L., Fuchs, C. S., Niedzwiecki, D., Zhang, S., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Giovannucci, E. L., Ng, K. & Meyerhardt, J. A., Jun 2018, In : JAMA Oncology. 4, 6, p. 783-790 8 p.

Research output: Contribution to journalArticle

34 Scopus citations

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Zhang, S., Niedzwiecki, D., Li, Y., Babic, A., Morales-Oyarvide, V., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Zoltick, E. S., Stampfer, M., Ng, K. & 5 others, Wu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & Fuchs, C. S., Jul 2018, In : PloS one. 13, 7, e0199244.

Research output: Contribution to journalArticle

1 Scopus citations

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

Smith, S. M., Godfrey, J., Ahn, K. W., DiGilio, A., Ahmed, S., Agrawal, V., Bachanova, V., Bacher, U., Bashey, A., Bolaños-Meade, J., Cairo, M., Chen, A., Chhabra, S., Copelan, E., Dahi, P. B., Aljurf, M., Farooq, U., Ganguly, S., Hertzberg, M., Holmberg, L. & 20 others, Inwards, D., Kanate, A. S., Karmali, R., Kenkre, V. P., Kharfan-Dabaja, M. A., Klein, A., Lazarus, H. M., Mei, M., Mussetti, A., Nishihori, T., Ramakrishnan Geethakumari, P., Saad, A., Savani, B. N., Schouten, H. C., Shah, N., Urbano-Ispizua, A., Vij, R., Vose, J., Sureda, A. & Hamadani, M., Jun 15 2018, In : Cancer. 124, 12, p. 2541-2551 11 p.

Research output: Contribution to journalArticle

16 Scopus citations

BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1

Zhu, S., Zhao, D., Yan, L., Jiang, W., Kim, J. S., Gu, B., Liu, Q., Wang, R., Xia, B., Zhao, J. C., Song, G., Mi, W., Wang, R. F., Shi, X., Lam, H. M., Dong, X., Yu, J., Chen, K. & Cao, Q., Dec 1 2018, In : Nature communications. 9, 1, 500.

Research output: Contribution to journalArticle

23 Scopus citations

Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel

Lara, P. N., Mayerson, E., Gertz, E., Tangen, C., Goldkorn, A., van Loan, M., Hussain, M., Gupta, S., Zhang, J., Twardowski, P., Quinn, D. I., Vogelzang, N. J., Thompson, I. & Agarwal, N., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii275-viii276

Research output: Contribution to journalArticle

Open Access

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M. G., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.

Research output: Contribution to journalArticle

1 Scopus citations
1 Scopus citations

BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors

Doxie, D. B., Greenplate, A. R., Gandelman, J. S., Diggins, K. E., Roe, C. E., Dahlman, K. B., Sosman, J. A., Kelley, M. C. & Irish, J. M., Nov 2018, In : Pigment Cell and Melanoma Research. 31, 6, p. 708-719 12 p.

Research output: Contribution to journalArticle

5 Scopus citations

BRAF in lung cancers: Analysis of patient cases reveals recurrent BRAF mutations, fusions, kinase duplications, and concurrent alterations

Sheikine, Y., Pavlick, D., Klempner, S. J., Trabucco, S. E., Chung, J. H., Rosenzweig, M., Wang, K., Velcheti, V., Frampton, G. M., Peled, N., Murray, M., Chae, Y. K., Albacker, L. A., Gay, L., Husain, H., Suh, J. H., Millis, S. Z., Reddy, V. P., Elvin, J. A., Hartmaier, R. J. & 9 others, Dowlati, A., Stephens, P., Ross, J. S., Bivona, T. G., Miller, V. A., Ganesan, S., Schrock, A. B., Ou, S. H. I. & Ali, S. M., Jan 1 2018, In : JCO Precision Oncology. 2

Research output: Contribution to journalArticle

8 Scopus citations

BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy

Johnson, D. B., Childress, M. A., Chalmers, Z. R., Frampton, G. M., Ali, S. M., Rubinstein, S. M., Fabrizio, D., Ross, J. S., Balasubramanian, S., Miller, V. A., Stephens, P. J., Sosman, J. A. & Lovly, C. M., May 2018, In : Pigment Cell and Melanoma Research. 31, 3, p. 432-436 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

Gravis, G., Boher, J. M., Chen, Y. H., Liu, G., Fizazi, K., Carducci, M. A., Oudard, S., Joly, F., Jarrard, D. M., Soulie, M., Eisenberger, M. J., Habibian, M., Dreicer, R., Garcia, J. A., Hussain, M. H. M., Kohli, M., Vogelzang, N. J., Picus, J., DiPaola, R. & Sweeney, C., Jun 2018, In : European urology. 73, 6, p. 847-855 9 p.

Research output: Contribution to journalArticle

63 Scopus citations

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis

Mulligan, J. K., Patel, K., Williamson, T., Reaves, N., Carroll, W., Stephenson, S. E., Gao, P., Drake, R. R., Neely, B. A., Tomlinson, S., Schlosser, R. J. & Atkinson, C., Sep 1 2018, In : Mucosal Immunology. 11, 5, p. 1375-1385 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model

Simone, B. A., Palagani, A., Strickland, K., Ko, K., Jin, L., Lim, M. K., Dan, T. D., Sarich, M., Monti, D. A., Cristofanilli, M. & Simone, N. L., Jul 3 2018, In : Cell Cycle. 17, 13, p. 1536-1544 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

Case report of prostate ductal adenocarcinoma presenting with hematuria

Pawlowski, J., Swanson, G. P., Mahalingam, D. & Ha, C. S., Jul 2018, In : Urology Case Reports. 19, p. 63-64 2 p.

Research output: Contribution to journalArticle

CCR5 Governs DNA damage repair and breast cancer stem cell expansion

Jiao, X., Velasco-Velazquez, M. A., Wang, M., Li, Z., Rui, H., Peck, A. R., Korkola, J. E., Chen, X., Xu, S., DuHadaway, J. B., Guerrero-Rodriguez, S., Addya, S., Sicoli, D., Mu, Z., Zhang, G., Stucky, A., Zhang, X., Cristofanilli, M., Fatatis, A., Gray, J. W. & 3 others, Zhong, J. F., Prendergast, G. C. & Pestell, R. G., Apr 1 2018, In : Cancer Research. 78, 7, p. 1657-1671 15 p.

Research output: Contribution to journalArticle

30 Scopus citations

CD95/fas ligand mRNA is toxic to cells

Putzbach, W., Haluck-Kangas, A., Gao, Q. Q., Sarshad, A. A., Bartom, E. T., Stults, A., Qadir, A. S., Hafner, M. & Peter, M. E., Oct 2018, In : eLife. 7, e38621.

Research output: Contribution to journalArticle

5 Scopus citations

Cell-free DNA and circulating tumor cells: Comprehensive liquid biopsy analysis in advanced breast cancer

Rossi, G., Mu, Z., Rademaker, A. W., Austin, L. K., Strickland, K. S., Costa, R. L. B., Nagy, R. J., Zagonel, V., Taxter, T. J., Behdad, A., Wehbe, F. H., Platanias, L. C., Gradishar, W. J. & Cristofanilli, M., Feb 1 2018, In : Clinical Cancer Research. 24, 3, p. 560-568 9 p.

Research output: Contribution to journalArticle

44 Scopus citations

Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 chaarted trial

Kyriakopoulos, C. E., Chen, Y. H., Carducci, M. A., Liu, G., Jarrard, D. F., Hahn, N. M., Shevrin, D. H., Dreicer, R., Hussain, M., Eisenberger, M., Kohli, M., Plimack, E. R., Vogelzang, N. J., Picus, J., Cooney, M. M., Garcia, J. A., DiPaola, R. S. & Sweeney, C. J., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1080-1087 8 p.

Research output: Contribution to journalArticle

173 Scopus citations

Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer

Cheng, H. H., Plets, M., Li, H., Higano, C. S., Tangen, C. M., Agarwal, N., Vogelzang, N. J., Hussain, M., Thompson, I. M., Tewari, M. & Yu, E. Y., Feb 1 2018, In : Prostate. 78, 2, p. 121-127 7 p.

Research output: Contribution to journalArticle

3 Scopus citations

Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States

Grunwald, M. R., Stein, B. L., Boccia, R. V., Oh, S. T., Paranagama, D., Parasuraman, S., Colucci, P. & Mesa, R., Dec 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 12, p. 788-795.e2

Research output: Contribution to journalArticle

4 Scopus citations

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

Turner, N. C., Finn, R. S., Martin, M., Im, S. A., DeMichele, A., Ettl, J., Diéras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D. R., Mori, A., Giorgetti, C., Iyer, S., Huang Bartlett, C. & Gelmon, K. A., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 669-680 12 p.

Research output: Contribution to journalArticle

28 Scopus citations

Clinical practice guidelines in oncology

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Isakoff, S. J., Lyons, J., Kelly Marcom, P., Mayer, I. A., McCormick, B., Moran, M. S., O’Regan, R. M., Patel, S. A. & 13 others, Pierce, L. J., Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Sitapati, A., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M. L., Ward, J. H., Kumar, R. & Shead, D. A., Mar 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 3, p. 310-320 11 p.

Research output: Contribution to journalArticle

120 Scopus citations

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, G. C., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L. & 16 others, Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Li, S., Miranda, R. N., Medeiros, L. J., Li, Y., Xu-Monette, Z. Y. & Young, K. H., Jun 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

Research output: Contribution to journalArticle

14 Scopus citations

Clotting-Factor Concentrations 5 Days after Discontinuation of Warfarin

Benzon, H. T., Asher, Y., Kendall, M. C., Vida, L., McCarthy, R. J. & Green, D., Aug 1 2018, In : Regional anesthesia and pain medicine. 43, 6, p. 616-620 5 p.

Research output: Contribution to journalArticle

1 Scopus citations